EXACT Therapeutics AS (FRA:56F)

Germany flag Germany · Delayed Price · Currency is EUR
0.0685
-0.0345 (-33.50%)
At close: Nov 28, 2025
-85.73%
Market Cap8.87M
Revenue (ttm)n/a
Net Income (ttm)-6.08M
Shares Outn/a
EPS (ttm)-0.12
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0685
Previous Close0.1030
Day's Range0.0685 - 0.0685
52-Week Range0.0685 - 0.5050
Betan/a
RSI38.51
Earnings DateDec 25, 2025

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 12
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 56F
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements

News

There is no news available yet.